Nanomedicine in cancer treatment

Nanomedicine in cancer treatment

Cancer is considered one of the most challenging health care problems that represent about one-third of the leading causes of death and disability around the globe. Though various licensed medications can be used for cancer therapy, looking for ways that can improve the efficiency of the treatment such as Nanomedicine is vital

To defeat the difficulties and side effects arising from existing chemotherapy and radiotherapy procedures, In recent years, Nanomedicine has attracted scientists because of its enormous properties such as its petite size, capacity to pack various drugs and large surface area, and strength to increase the absorption of conjugated.       

v  Currently, almost 50 Nanomedicine have been approved by the FDA for clinical usage since 1995.

v  They have been used to treat adult cancers including ovarian cancer, Karposi's sarcoma, and multiple myeloma.

v  The first cancer nanomedicine approved by the US Food and Drug Administration was Doxil.

v  Recently, Northwestern Medicine scientists successfully applied magnetic nanoparticles to damage tumor cells in animal models.

Nanoparticles carrying drug molecules are attached to immune cells ( T-cells). The purpose is when the T-cells reach a tumor the nanoparticles deliver the drug molecules, which cause the T-cells to reproduce. If enough T-cells are reproduced in the cancer tumor, that cancer can be destroyed.

Nanomedicine as an innovative and promising treatment option for cancer shows several advantages and provides new possibilities for early detection, treatment, diagnosis and recovery of cancer.